{
    "2018-08-20": [
        [
            {
                "time": "2018-01-02",
                "original_text": "AbbVie donates $100M to Ronald McDonald House Charities",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "donates",
                        "Ronald McDonald House Charities"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "8 Undervalued Biotech Stocks to Watch",
                "features": {
                    "keywords": [
                        "undervalued",
                        "biotech",
                        "stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Bay Area's 10th life science IPO this year raises $26M as No. 11 hopes to fetch $86M",
                "features": {
                    "keywords": [
                        "Bay Area",
                        "life science",
                        "IPO",
                        "raises"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "life science"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Ronald McDonald House Houston receives its largest gift, part of $100M from AbbVie",
                "features": {
                    "keywords": [
                        "Ronald McDonald House Houston",
                        "largest gift",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "Allergan’s International Business Segment in Q2 2018",
                "features": {
                    "keywords": [
                        "Allergan",
                        "International Business Segment",
                        "Q2 2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "Allergan’s US Specialized Therapeutics Segment in Q2 2018",
                "features": {
                    "keywords": [
                        "Allergan",
                        "US Specialized Therapeutics Segment",
                        "Q2 2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}